首页> 美国卫生研究院文献>Molecules >Substituted Piperazines as Novel Potential Radioprotective Agents
【2h】

Substituted Piperazines as Novel Potential Radioprotective Agents

机译:取代哌嗪作为新型潜在的辐射防护剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The increasing risk of radiation exposure underlines the need for novel radioprotective agents. Hence, a series of novel 1-(2-hydroxyethyl)piperazine derivatives were designed and synthesized. Some of the compounds protected human cells against radiation-induced apoptosis and exhibited low cytotoxicity. Compared to the previous series of piperazine derivatives, compound exhibited a radioprotective effect on cell survival in vitro and low toxicity in vivo. It also enhanced the survival of mice 30 days after whole-body irradiation (although this increase was not statistically significant). Taken together, our in vitro and in vivo data indicate that some of our compounds are valuable for further research as potential radioprotectors.
机译:辐射暴露的风险不断增加,凸显了对新型放射防护剂的需求。因此,设计和合成了一系列新颖的1-(2-羟乙基)哌嗪衍生物。一些化合物保护人类细胞免受辐射诱导的细胞凋亡,并表现出低细胞毒性。与先前的哌嗪衍生物系列相比,该化合物对体外细胞存活和体内低毒性表现出放射防护作用。它也增强了全身照射后30天小鼠的存活率(尽管这种增加在统计学上并不显着)。综上所述,我们的体内和体外数据表明,我们的某些化合物作为潜在的辐射防护剂,对于进一步的研究非常有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号